Development of granulomatous hepatitis during treatment with interferon-alpha 2b

Dig Dis Sci. 1995 Oct;40(10):2117-8. doi: 10.1007/BF02208993.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Antiviral Agents / adverse effects*
  • Biopsy
  • Chemical and Drug Induced Liver Injury* / etiology*
  • Chemical and Drug Induced Liver Injury* / pathology
  • Granuloma / chemically induced*
  • Granuloma / pathology
  • Hepatitis B / complications
  • Hepatitis B / therapy
  • Hepatitis C / complications
  • Hepatitis C / therapy
  • Hepatitis, Chronic / complications
  • Hepatitis, Chronic / therapy
  • Humans
  • Interferon alpha-2
  • Interferon-alpha / adverse effects*
  • Liver / pathology
  • Liver Diseases / pathology
  • Male
  • Recombinant Proteins

Substances

  • Antiviral Agents
  • Interferon alpha-2
  • Interferon-alpha
  • Recombinant Proteins